Muñiz Antonio E
Dallas Regional Medical Center, Mesquite, TX, USA.
Pediatr Emerg Care. 2012 Feb;28(2):170-3. doi: 10.1097/PEC.0b013e318244788f.
The importance of thrombolytic therapy within the first 3 hours of onset of symptoms of an acute stroke has been stressed, and in consequence, the diagnosis is most commonly made based on clinical grounds. Intracranial hemorrhage is the major life-threatening complication with the use of thrombolytic therapy. Because of the very small time window before administering thrombolytics, it is often not possible to investigate the unusual causes of a stroke that occurs most often in children.
This study aimed to present the decision and risk of thrombolysis for an acute ischemic stroke in children.
A case of a teenager with an acute ischemic stroke who received thrombolysis and had resolution of symptoms.
Thrombolytic therapy is effective in acute ischemic strokes; however, in children, one must consider and exclude stroke mimickers and recognize that potentially life-threatening bleeding complicates the use of these medications.
急性中风症状发作后3小时内进行溶栓治疗的重要性已得到强调,因此,诊断通常基于临床依据。颅内出血是使用溶栓治疗的主要危及生命的并发症。由于在给予溶栓药物之前的时间窗口非常小,通常无法调查儿童中最常见的中风的不寻常病因。
本研究旨在阐述儿童急性缺血性中风溶栓治疗的决策和风险。
一名患有急性缺血性中风的青少年接受了溶栓治疗,症状得到缓解。
溶栓治疗对急性缺血性中风有效;然而,对于儿童,必须考虑并排除类似中风的疾病,并认识到潜在的危及生命的出血会使这些药物的使用变得复杂。